The Challenges of Treating Covid-19: Lessons from Gilead’s Remdesivir As the first and only FDA approved antiviral treatment for Covid-19, Gilead's remdesivir has been shown to prevent individuals at high risk of severe disease from being hospitalized. However, inherent eligibility and accessibility restrictions reduce its effectiveness in the larger population.